MENU
SMMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Summit Therapeutics (SMMT) Earnings Date & Reports
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
SMMT is expected to report earnings to fall 22.70% to -28 cents per share on November 11
Q3'26
Est.
$-0.29
Q2'26
Missed
by $0.09
Q1'26
Missed
by $0.04
Q4'25
Missed
by $0.31
Q3'25
Beat
by $0.04
The last earnings report on July 23 showed earnings per share of -37 cents, missing the estimate of -28 cents. With 2.54M shares outstanding, the current market capitalization sits at 12.35B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of novel medicines
Industry Biotechnology
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 305 203-2034
Employees
265
Web
https://www.smmttx.com